Skip to main content

Ghost Tree Capital, LLC

SEC CIK
0001595851
Latest filing
Nov 14, 2024

ACAD holding history

Acadia Pharmaceuticals Inc in every 13F filed by Ghost Tree Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ACAD overviewAll 13F holders of ACADFull Q3 2024 holdings

Shares (Q3 2024)
0
Sold out in Q3 2024
Value
$0
% of portfolio
0.0%
Quarters held
4
Since Q3 2023
Holdings of ACAD by Ghost Tree Capital, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20240$00.0%−225,000−100.0%Sold outHolders
Q2 2024225,000$3.66M1.3%00.0%UnchangedHolders
Q1 2024225,000$4.16M1.3%+175,000+350.0%AddedHolders
Q4 202350,000$1.57M0.9%−30,000−37.5%ReducedHolders
Q3 202380,000$1.67M0.8%+80,000NewHolders